Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
10.78
-0.08 (-0.74%)
Apr 28, 2026, 3:04 PM CST

SHE:002399 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,3461,6891,7662,1392,944
Short-Term Investments
--206.2--
Trading Asset Securities
1,484868.42414.181,312981.16
Cash & Short-Term Investments
2,8302,5572,3863,4503,925
Cash Growth
10.66%7.18%-30.85%-12.10%8.59%
Accounts Receivable
1,3681,1871,2751,6261,543
Other Receivables
301.39329.63121.89134.82243.81
Receivables
1,6691,5161,3961,7611,787
Inventory
4,4475,3946,6546,8444,708
Prepaid Expenses
--111.28--
Other Current Assets
205.25153.4356.43334.53349.43
Total Current Assets
9,1519,62110,60412,39010,770
Property, Plant & Equipment
2,3882,6482,8492,4772,537
Long-Term Investments
1,7661,8232,5142,4642,618
Goodwill
2,3052,3572,3222,3512,152
Other Intangible Assets
326.57400.41370.78522.87546.87
Long-Term Deferred Tax Assets
320.44282.51320.5141.48121.72
Long-Term Deferred Charges
178.96185.6518.64244.71241.88
Other Long-Term Assets
195.3225.48203.87224.95120.85
Total Assets
16,63217,34419,20320,81619,108
Accounts Payable
257.07299.69306.34427.43385.79
Accrued Expenses
469.4399.46388377.51398.43
Short-Term Debt
1,7701,8391,0692,3851,886
Current Portion of Long-Term Debt
834.59528.222,5561,6351,382
Current Portion of Leases
30.138.8237.835.6931.75
Current Income Taxes Payable
107.32120.26157.18112.3113.2
Current Unearned Revenue
250.79264.28362.05433.88383.79
Other Current Liabilities
233.65209.56110.24168.2210.34
Total Current Liabilities
3,9533,6994,9865,5764,791
Long-Term Debt
298.061,0811,8102,2972,250
Long-Term Leases
40.3257.7790.42110.75104
Long-Term Unearned Revenue
42.5827.2830.4332.5516.67
Pension & Post-Retirement Benefits
-23.2235.2732.49120.65
Long-Term Deferred Tax Liabilities
207.07242.49252.57328.92275.36
Other Long-Term Liabilities
10.1910.3510.1529.3926.44
Total Liabilities
4,5525,1417,2158,4077,585
Common Stock
1,4671,4671,4671,4671,467
Additional Paid-In Capital
5,8645,8657,5295,8595,944
Retained Earnings
4,5664,5783,9414,8614,184
Comprehensive Income & Other
133.96238.17-1,024125.52-183.36
Total Common Equity
12,03112,14911,91312,31311,411
Minority Interest
49.2353.4575.2396.72111.96
Shareholders' Equity
12,08012,20211,98812,40911,523
Total Liabilities & Equity
16,63217,34419,20320,81619,108
Total Debt
2,9743,5455,5636,4645,654
Net Cash (Debt)
-143.41-987.34-3,177-3,013-1,729
Net Cash Per Share
-0.10-0.67-2.15-2.05-1.18
Filing Date Shares Outstanding
1,4671,4671,4671,4671,467
Total Common Shares Outstanding
1,4671,4671,4671,4671,467
Working Capital
5,1985,9225,6186,8145,978
Book Value Per Share
8.208.288.128.397.78
Tangible Book Value
9,4009,3919,2209,4398,712
Tangible Book Value Per Share
6.416.406.286.435.94
Land
33.7434.513433.4330.61
Buildings
1,8371,7881,9151,4801,450
Machinery
2,5051,9961,9611,8921,719
Construction In Progress
60.7697.77468.72394.53425.35
Leasehold Improvements
--15.43--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.